Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Apimeds Pharmaceuticals (AMEX:APUS) through any online brokerage.
There are no as such competitors for Apimeds Pharmaceuticals.
There is no analysis for Apimeds Pharmaceuticals to provide a consensus price target.
The stock price for Apimeds Pharmaceuticals (AMEX: APUS) is $1.29 last updated June 12, 2026 at 3:49 PM EDT.
There are no upcoming dividends for Apimeds Pharmaceuticals.
Apimeds Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Apimeds Pharmaceuticals.
Apimeds Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.